WEDGE CAPITAL MANAGEMENT L L P/NC – United Therapeutics Corporation Transaction History
WEDGE CAPITAL MANAGEMENT L L P/NC portfolio value:
$34.65M
portfolio value
WEDGE CAPITAL MANAGEMENT L L P/NC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +3.42% | 5.47K shares | -3.05M | $209.38 | 165.50K |
Q2 2022 | share | Decrease | -9.93% | -17.63K shares | 5.83M | $235.64 | 160.02K |
Q1 2022 | share | Increase | +9.60% | 15.56K shares | -3.15M | $179.41 | 177.66K |
Q4 2021 | share | Increase | +2.44% | 3.86K shares | 5.81M | $215.18 | 162.09K |
Q3 2021 | share | Decrease | -14.00% | -25.75K shares | -3.80M | $184.58 | 158.23K |
Q2 2021 | share | Decrease | -2.97% | -5.63K shares | 1.29M | $179.41 | 183.99K |
Q1 2021 | share | Decrease | -4.77% | -9.49K shares | 1.49M | $167.27 | 189.62K |
Q4 2020 | share | Decrease | -22.14% | -56.61K shares | 4.39M | $151.79 | 199.11K |
Q3 2020 | share | Decrease | -10.85% | -31.12K shares | -8.88M | $101 | 255.72K |
Q2 2020 | share | Increase | 0.00% | 286.85K shares | 34.70M | $121 | 286.85K |
Q2 2019 | share | Decrease | -100.00% | -335.15K shares | -39.33M | $78.06 | 0 |
Q1 2019 | share | Increase | +13.45% | 39.73K shares | 7.16M | $117.37 | 335.15K |
Q4 2018 | share | Increase | +9.28% | 25.07K shares | -2.4M | $108.9 | 295.41K |
Q3 2018 | share | Decrease | -1.09% | -2.99K shares | 3.64M | $127.88 | 270.34K |
Q2 2018 | share | Decrease | -14.82% | -47.55K shares | -5.12M | $113.15 | 273.33K |
Q1 2018 | share | Decrease | -1.15% | -3.73K shares | -11.97M | $112.36 | 320.89K |
Q4 2017 | share | Increase | +2725.83% | 313.14K shares | 46.68M | $147.95 | 324.63K |
Q3 2017 | share | Increase | +21.84% | 2.05K shares | 123K | $117.19 | 11.48K |
Q2 2017 | share | Increase | +16.88% | 1.36K shares | 131K | $129.73 | 9.42K |
Q1 2017 | share | Increase | +2.71% | 213 shares | -34K | $135.38 | 8.06K |
Q4 2016 | share | Decrease | -4.86% | -401 shares | 151K | $143.43 | 7.85K |
Q3 2016 | share | Decrease | -13.01% | -1.23K shares | -30K | $118.08 | 8.25K |
Q2 2016 | share | Increase | +22.99% | 1.77K shares | 145K | $105.92 | 9.49K |
Q1 2016 | share | Increase | 0.00% | 7.71K shares | 860K | $111.43 | 7.71K |